USC News

Menu Saturday, December 15, 2018 65° Clear

Research

Search
HealthScience/Technology
postpartum bleeding drug activation
Some important conditions are treated by misoprostol, including ulcers, bleeding inflammation, pain and labor. Illustrated here is misoprostol in the binding site of the hormone prostaglandin E2 receptor 3. (Illustration/Yekaterina Kadyshevskaya)

Better drug to save mothers’ lives during childbirth may be on the way

Scientists at the USC Michelson Center for Convergent Bioscience and Stanford University take first step toward a safer drug for reducing postpartum bleeding.